Patents by Inventor Jose L. G. Flores

Jose L. G. Flores has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
    Patent number: 6863886
    Abstract: An enzymatic method is provided for treating ophthalmic disorders of the mammalian eye. Prevention of neovascularization and the increased rate of clearance from the vitreous of materials toxic to retina is accomplished by administering an amount of hyaluronidase effective to liquefy the vitreous humor of the treated eye without causing toxic damage to the eye. Liquefaction of the vitreous humor increases the rate of liquid exchange from the vitreal chamber. This increase in exchange removes those materials and conditions whose presence causes ophthalmological and retinal damage.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: March 8, 2005
    Assignee: Advanced Corneal Systems
    Inventors: Hampar Karageozian, Vicken Karageozian, Maria C. Kenney, Jose L. G. Flores, Gabriel Arturo Carpio Aragon, Anthony B. Nesburn
  • Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
    Publication number: 20030170224
    Abstract: An enzymatic method is provided for treating ophthalmic disorders of the mammalian eye. Prevention of neovascularization and the increased rate of clearance from the vitreous of materials toxic to retina is accomplished by administering an amount of hyaluronidase effective to liquefy the vitreous humor of the treated eye without causing toxic damage to the eye. Liquefaction of the vitreous humor increases the rate of liquid exchange from the vitreal chamber. This increase in exchange removes those materials and conditions whose presence causes ophthalmological and retinal damage.
    Type: Application
    Filed: February 21, 2003
    Publication date: September 11, 2003
    Inventors: Hampar Karageozian, Vicken Karageozian, Maria C. Kenney, Jose L.G. Flores, Gabriel Arturo Carpio Aragon, Anthony B. Nesburn
  • Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
    Patent number: 6610292
    Abstract: An enzymatic method is provided for treating ophthalmic disorders of the mammalian eye. Prevention of neovascularization and the increased rate of clearance from the vitreous of materials toxic to the retina is accomplished by administering an amount of hyaluronidase effective to liquefy the vitreous humor of the treated eye without causing toxic damage to the eye. Liquefaction of the vitreous humor increases the rate of liquid exchange from the vitreal chamber. This increase in exchange removes those materials and conditions whose presence causes ophthalmological and retinal damage.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: August 26, 2003
    Assignee: ISTA Pharmaceuticals, Inc.
    Inventors: Hampar Karageozian, Vicken Karageozian, Maria C. Kenney, Jose L. G. Flores, Gabriel Arturo Carpio Aragon, Anthony B. Nesburn
  • USE OF HYALURONIDASE IN THE MANUFACTURE OF AN OPHTHALMIC PREPARATION FOR LIQUEFYING VITREOUS HUMOR IN THE TREATMENT OF EYE DISORDERS
    Publication number: 20020164316
    Abstract: An enzymatic method is provided for treating ophthalmic disorders of the mammalian eye. Prevention of neovascularization and the increased rate of clearance from the vitreous of materials toxic to retina is accomplished by administering an amount of hyaluronidase effective to liquefy the vitreous humor of the treated eye without causing toxic damage to the eye. Liquefaction of the vitreous humor increases the rate of liquid exchange from the vitreal chamber. This increase in exchange removes those materials and conditions whose presence causes ophthalmological and retinal damage.
    Type: Application
    Filed: November 19, 1999
    Publication date: November 7, 2002
    Inventors: HAMPAR KARAGEOZIAN, VIKEN KARAGEOZIAN, MARIA C. KENNEY, JOSE L. G. FLORES, GABRIEL ARTURO CARPIO ARAGON, ANTHONY B. NESBURN